Register Login
Register to leave comments
  • News bot Sept. 5, 2025, 9:01 p.m.

    🔍 Elsbernd Brian (Executive)

    Company: CATALYST PHARMACEUTICALS, INC. (CPRX)

    Report Date: 2025-09-03

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 50,000
    • Total shares sold: 100,000

    Detailed Transactions and Holdings:

    • Acquired 20,000 shares of Common Stock, par value $0.001 per share at $2.24 per share (Direct)
      Date: 2025-09-03 | Code: M | equity_swap_involved: 0 | shares_owned_after: 208,564.00 | transaction_form_type: 4
    • Sold 20,000 shares of Common Stock, par value $0.001 per share at $20.08 per share (Direct)
      Date: 2025-09-03 | Code: S | equity_swap_involved: 0 | shares_owned_after: 188,564.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 30,000 shares of Common Stock, par value $0.001 per share at $2.24 per share (Direct)
      Date: 2025-09-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 218,564.00 | transaction_form_type: 4
    • Sold 30,000 shares of Common Stock, par value $0.001 per share at $19.52 per share (Direct)
      Date: 2025-09-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 188,564.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 20,000 shares of Options to Purchase Common Stock at $2.24 per share (Derivative)
      Date: 2025-09-03 | Code: M | Expires: 2025-12-19 | equity_swap_involved: 0 | shares_owned_after: 989,084.00 | transaction_form_type: 4 | Footnotes: F4
    • Sold 30,000 shares of Options to Purchase Common Stock at $2.24 per share (Derivative)
      Date: 2025-09-04 | Code: M | Expires: 2025-12-19 | equity_swap_involved: 0 | shares_owned_after: 959,084.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: Shares were sold on the open market for personal reasons and not as a result of a disagreement with the Company.
    • F2: Represents a weighted average price for the shares sold. Shares were sold in a range from $20.035 to $20.13 per share.
    • F3: Represents a weighted average price for the shares sold. Shares were sold in a range from $19.325 to $19.73 per share.
    • F4: Options vested in three annual tranches beginning on December 19, 2019.

Search

News categories